without comments
For pharma, this is the curve that needs to be re-shaped:
Source: Morgan Stanley
Written by admin
February 19th, 2010 at 10:28 am
Posted in Chart of the Day, Clinical trial analysis
Tagged with clinical trials, pharmaceuticals, phase I, phase II, phase III, phase IV, research and development
Name (required)
Mail (will not be published) (required)
Website
www.trialdox.com
